Xylo Technologies Stock Today
| XYLO Stock | 5.00 0.10 1.96% |
PerformanceGood
| Odds Of DistressQuite High
|
Xylo Technologies is selling at 5.00 as of the 20th of March 2025; that is 1.96% down since the beginning of the trading day. The stock's open price was 5.1. Xylo Technologies has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Xylo Technologies symbol was changed from MDGS,XLYO on 19th of April 2024. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 5th of August 2015 | Category Healthcare | Classification Health Care |
Xylo Technologies is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 732.07 K outstanding shares of which 5.34 K shares are at this time shorted by private and institutional investors with about 0.54 trading days to cover. More on Xylo Technologies
Moving together with Xylo Stock
Moving against Xylo Stock
Xylo Stock Highlights
| Older Symbol | MDGS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Drugs (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xylo Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Xylo Technologies' financial leverage. It provides some insight into what part of Xylo Technologies' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xylo Technologies (XYLO) is traded on NASDAQ Exchange in USA. It is located in 10 Hanechoshet, Tel Aviv, Israel, 6971072 and employs 84 people. Xylo Technologies was previously known as MDGS Old and was traded on NASDAQ Exchange under the symbol MDGS. Xylo Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.73 M. Xylo Technologies conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 732.07 K outstanding shares of which 5.34 K shares are at this time shorted by private and institutional investors with about 0.54 trading days to cover.
Xylo Technologies generates negative cash flow from operations
Check Xylo Technologies Probability Of Bankruptcy
Ownership AllocationXylo Technologies maintains 9.9 (%) of its outstanding shares held by insiders and 7.95 (%) owned by institutional investors.
Check Xylo Ownership Details
Xylo Technologies Historical Income Statement
Xylo Stock Against Markets
Already Invested in Xylo Technologies?
The danger of trading Xylo Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Xylo Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Xylo Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Xylo Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Xylo Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xylo Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xylo Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xylo Technologies Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xylo Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Xylo Stock, please use our How to Invest in Xylo Technologies guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylo Technologies. If investors know Xylo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylo Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (23.20) | Revenue Per Share | Quarterly Revenue Growth (0.64) | Return On Assets | Return On Equity |
The market value of Xylo Technologies is measured differently than its book value, which is the value of Xylo that is recorded on the company's balance sheet. Investors also form their own opinion of Xylo Technologies' value that differs from its market value or its book value, called intrinsic value, which is Xylo Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylo Technologies' market value can be influenced by many factors that don't directly affect Xylo Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylo Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylo Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylo Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.